Of note, some authors suggested that the presence of anti-PLA2R antibodies in patients with SMN might result from the co-incidental simultaneous development of PMN and a systemic disease, such as SLE or a malignancy [18]. Here, PLA2R1 is linked to systemic lupus erythematosus.